Sanofi gets priority U.S. FDA review for sutimlimab product
Reuters
URL: https://www.reuters.com/article/us-sano ... SKBN22Q0JI
Category: healthNews
Published: Thu, 14 May 2020 01:31:28 -0400
Description: French healthcare company Sanofi said on Thursday that the U.S. Food & Drug Administration (FDA) regulator had granted a priority review for Sanofi's sutimlimab product, which treats hemolysis in adults suffering from cold agglutinin disease.